RxDoctor Payments Data

Tara Wells

Family · Helena, MTNPI 1770080004

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 89.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $7,189 and has fallen 81.3% since, to $1,347 in 2025. Among family clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,611in general payments, 2019–2025

Across 191 payments — averaging $50.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$9K
  • Corcept Therapeutics$236
  • Sunovion Pharmaceuticals Inc.$222
  • Lilly USA, LLC$138
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$102
  • Novo Nordisk$78
  • plus $256 from 8 others

What the payments were for

  • Speaking & faculty fees$4,50047%
  • Travel & lodging$1,94120%
  • Food & beverage$3,11132%
  • Education$591%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,611 in reported general payments places this provider in the 95th percentile of 481 family providers in Montana.

See all family providers in Montana

Medicare billing

Part B allowed, 2024
$23,794
Medicare patients
36
Services billed
241

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl123$18,059
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$11,399
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen74$1,395
Buprenorphine Hcl42$1,359
Ondansetron OdtOndansetron18$915
Oxycodone Hcl52$868
Gabapentin60$837
Bupropion XlBupropion Hcl27$819
Albuterol Sulfate HfaAlbuterol Sulfate29$793
Clonazepam111$789
Lisdexamfetamine Dimesylate14$631
Lurasidone Hcl26$620
Atomoxetine Hcl11$567
Modafinil18$536
Lamotrigine31$475

Paid to pharmacies, not to this prescriber.

Other family in Helena

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →